22 December 2020 | Will Smith Associate

In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This case concerned the licensing of patented technology, specifically the use of licence terms relating to the control of proceedings. 

Click here to read more >

About the Author

william smith module

Will Smith
I'm a senior associate in our Intellectual Property Group in London and have been with Bird & Bird since 2011. Today, I work on contentious and non-contentious matters concerning IP rights both in the UK and on a pan-European basis.

Direct: +44 (0)20 7415 6000

[email protected]

You may also be interested in